Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex99-1.htm |
| EX-32.1 - EXHIBIT 32.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex31-1.htm |
| EX-21 - EXHIBIT 21 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex21.htm |
| 10-K - FORM 10-K - FENNEC PHARMACEUTICALS INC. | tm205262d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (file no. 333-221091), S-8 (on file no. 333-232353), S-3 (file no. 333-221093) and S-3 (file no. 333-219884) of Fennec Pharmaceuticals Inc. (the "Company") of our report dated February 14, 2020 relating to the consolidated financial statements as of December 31, 2019, which appear in the Annual Report on Form 10-K for the year ended December 31, 2019.
| /s/ HASKELL & WHITE LLP | |
| HASKELL & WHITE LLP |
Irvine, California
February 14, 2020
